










online, as suDefining the Patient Acceptable Symptom State Using
the Forgotten Joint Score 12 After Hip ArthroscopyPatrick G. Robinson, M.R.C.S., M.Sc.(Res), Paul Gaston, F.R.C.S.(Orth),
Thomas R. Williamson, M.B.Ch.B., Iain R. Murray, F.R.C.S.(Orth), M.F.S.E.M., Ph.D.,
Julian F. Maempel, F.R.C.S.(Orth), Conor S. Rankin, M.B.Ch.B.,
Deborah J. MacDonald, B.A.(Hons), and David F. Hamilton, Ph.D.Purpose: To contextualize the Forgotten Joint Score (FJS-12) by identifying a patient acceptable symptomatic state
(PASS) threshold for patients undergoing hip arthroscopy and to investigate factors which correlated with postoperative
FJS-12 score. Methods: All patients who underwent hip arthroscopy for femoroacetabular impingement (FAI) under the
care of a single surgeon between January 2018 and November 2019 were prospectively identified and included. Exclusion
criteria were Tönnis classification grade 2 or greater. Data (including FJS-12, EuroQol-5 Dimension-5L [EQ-5D-5L], visual
analog scale (VAS), and 12-item International Hip Outcome Tool (iHOT-12) scores) were available before surgery and at a
minimum of 1 year after surgery. PASS was calculated using an anchor-based approach and receiver operator charac-
teristic curve analysis. Pearson correlation analysis was used to correlate preoperative and postoperative factors with
postoperative FJS-12 score. Results: Seventy-seven patients (54 female, 23 male; mean age 30.3 years [standard devi-
ation {SD} 8.2]) were included. Linked longitudinal follow-up data were available for 65 patients (84%) at a mean of 23.8
months (SD 6.4). Six patients required reoperation. Mean postoperative FJS-12 score was 46.5 (SD 33.1) and mean
change in score was 27.2 (SD 30.6, P < .001). The PASS threshold for the FJS-12 was 38.5 (sensitivity 80%, specificity
88%), and the area under the curve was 0.852 (95% confidence interval 0.752-0.951). Overall, 53.8% of patients ach-
ieved this score. Postoperative FJS-12 score has moderate correlations with preoperative EQ-5D-5L, iHOT-12, and FJS-12
scores, and strong correlations with EQ-5D-5L, iHOT-12 and VAS scores after surgery. Conclusions: We report a post-
operative PASS threshold of 38.5 points for the FJS-12 after hip arthroscopy for FAI in a United Kingdom population. This value
can act as a quantifiable target for clinicians using the FJS-12 to monitor patient outcomes in practice. FJS-12 has strong corre-
lations with EQ-5D-5L, iHOT-12, and VAS at a minimum 12 months after surgery. Level of Evidence: Level IV, case series 4.ip arthroscopy is an effective treatment for fem-Horoacetabular impingement (FAI) and labral pa-
thology,1,2 and a number of patient-reported outcome
measures (PROMs) have been used to quantify the
outcome of this treatment.3-7 The concept of joint
awareness is well suited for capturing reliable outcomes
for young, active patients undergoing hip arthroscopy,
and this is particularly true for high-functioning pa-
tients.8 The Forgotten Joint Score (FJS-12) is a well-
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Arthroscopy, Sports Medicine, and Rehabilitatiofor patients undergoing total hip and knee arthroplasty,
and it is has been shown to have the capability to
distinguish between high performing patients, which
previous described PROMs may have struggled with.9 It
is also being recognized as a useful tool for an athletic
population, secondary to its ability to distinguish been
good, very good, and excellent outcomes and, hence, is
less affected by a ceiling effect. In addition, it captures
what is most important to the patient compared with
surgeon-defined outcomes. It has now been used in aReceived January 27, 2021; accepted July 23, 2021.
Address correspondence to Thomas R. Williamson, M.B.Ch.B., Edinburgh
Medical School, University of Edinburgh, 49 Little France Crescent, EH16
4SA. E-mail: Tom.r.williamson@outlook.com
 2021 by the Arthroscopy Association of North America. Published by




n, Vol -, No - (Month), 2021: pp e1-e8 e1
e2 P. G. ROBINSON ET AL.number of sports surgery studies, including in the field
of hip arthroscopy, where it has been shown to be a
valid tool with minimal ceiling effect8,10 and in ACL
repair.11,12
Patient-reported outcome scores are very useful
research tools to quantify treatment success. These are
typically reported on a linear scale with an individual’s
score graded against upper and lower boundaries;
however, it can be challenging to meaningfully inter-
pret with regard to whether a “good” outcome has been
achieved. Indeed, postoperative outcomes are subjec-
tive and often closely tied to patients’ own expectations
from the surgery, which are varied and difficult to
quantify, although attempts have recently been made
in the literature.13 Postoperative satisfaction is a global
measure of success not exclusively tied to symptom-
atology or function after an operation, and in the
setting of arthroplasty it has been shown that patients’
expectations and experiences of the healthcare process
are just as important as achieving pain relief in pre-
dicting satisfaction after surgery.14 Patient selection for
surgery also plays a key role in outcomes and will often
also take into account these less quantitative
variables.15
A postoperative outcome score threshold above
which a patient is considered to have had a satisfactory
outcome is known as the patient acceptable symptom-
atic state (PASS).16 This is the point on the scoring
system that is associated with meeting outcome success
criteria as defined by patient’s acceptability of the
resultant symptom state, and it has been used widely in
both total hip and knee arthroplasty17-19 and in hip
arthroscopy.20-23 The PASS is a particularly useful
measure as it contextualizes whether the treatment has
been successful in a single postoperative evaluation.
The minimally clinical important difference (MCID) is
another helpful statistical description that is used to
interpret whether a meaningful change has been ach-
ieved in a PROM. It is the minimum value in score
points on a given scale which corresponds to a change
in symptomatology that the patient considers impor-
tant.24 Despite the increasing use of the FJS-12 in hip
arthroscopy, psychometric properties such as the PASS
and MCID have yet to be determined.
It is also useful to understand the baseline presenta-
tion factors that are associated with achieving a PASS
postoperatively to help counsel patients prior to sur-
gery. Preoperative predictors of success in hip arthros-
copy have previously been reported using the 12 item
International Hip Outcome Tool (iHOT-12)25 and the
33 item International Hip Outcome Tool (iHOT-33).26
In a recent scoping review of patient-related negative
predictive factors, Kuroda et al reported increasing age
and the presence of radiographic osteoarthritis as the
strongest predictors of a poorer outcome following hip
arthroscopy.27 Results from the Danish HipArthroscopy Registry of 2054 hip arthroscopy proced-
ures reported higher degrees of femoral and acetabular
chondral injury predicted inferior Copenhagen Hip and
Knee Outcome Scores, although the presence of low
grade chondral defects are often challenging to deter-
mine preoperatively.7,28 Beck et al reported larger
preoperative alpha angles were predictive of achieving
the PASS threshold on a visual analog scale of
satisfaction.29
The purpose of this study was to contextualize the
Forgotten Joint Score (FJS-12) by identifying a patient
acceptable symptomatic state (PASS) threshold for pa-
tients undergoing hip arthroscopy, and to investigate
factors which correlated with postoperative FJS-12
score. We hypothesized that our analysis would pro-
vide an FJS-12 threshold score that was sensitive and
specific for establishing whether patients have achieved
an acceptable symptomatic state postoperatively.
Methods
All patients undergoing primary hip arthroscopy for
FAI with labral tear by a single surgeon between
January 2018 and November 2019 were prospectively
collected and retrospectively analyzed. Exclusion
criteria included any patient with Tönnis classification
grade 2 or greater. Patients were diagnosed with FAI by
a single fellowship-trained hip surgeon (P.G) using
clinical history, examination, plain radiographs and
magnetic resonance arthrogram if appropriate and had
failed a trial of non-operative treatment including
analgesia and physiotherapy. Intra-articular injections
were used to confirm the origin of symptoms in cases of
doubt. Demographic data included age, gender, body
mass index (BMI), and Scottish Index of Multiple
Deprivation (SIMD) vingtile ranking (social deprivation
index).30 Patients completed preoperative FJS-12,8,10
iHOT-12,31 Tegner and EQ-5D-5L32 questionnaires 2
weeks before surgery at the pre-assessment clinic and at
a minimum of one year postoperatively. Plain ante-
roposterior radiographs were used to assess for cam
and/or pincer lesions as well as to calculate the lateral
center edge angle (LCEA), and assess Tönnis classifi-
cation. Patients self-reported the number of months for
which they had experienced symptoms prior to surgery.
Satisfaction data were also collected at a minimum of
one year postoperatively. Patients who did not respond
to postal questionnaires were telephoned by a member
of the research team.
Surgical Technique
The supine distractor was used for patient positioning.
Image intensifier was used to confirm joint distraction.
Superolateral and anterior portals were used to access
the hip joint. These were expanded with sequential
dilators to allow instrument access. The paralabral
recess was opened and a high-speed burr was used to
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a flat surface for anchor placement. If the labrum was
repairable, Stryker Cinchlock (Stryker, Mahwah, NJ,
USA) anchors were used in a vertical mattress fashion
with Cobraid sutures to repair the labrum. The traction
was then released and attention was turned to the
femoral head/neck junction. If a cam lesion was iden-
tified it was resected using a high-speed burr. Flexion
was used to reach the anterior most aspects of the neck.
An on-table impingement maneuver was performed to
assess clearance of the femoral neck from the acetab-
ulum under direct vision. Final orthogonal x-ray views
were obtained to ensure adequate bony resection. The
capsule was not repaired.
Rehabilitation
Rehabilitation was divided into four phases. In phase
one (0 e 10 days postoperatively), focus was on man-
aging pain and allowing flat-footed weightbearing with
the assistance of crutches. No range of movement re-
strictions are enforced for those undergoing labral
debridement however, those receiving repair are
restricted from hip flexion for four weeks and no hip
flexion and internal rotation for 12 weeks. In phase two
(10 days to 4 weeks), patients can disregard their
crutches and begin range of movement, muscle
recruitment and gait patterning. In phase 3 (>4 weeks),
progression of rehabilitation through this stage is gov-
erned by having a pain-free and non-irritable hip, a
normal gait pattern, optimal lower limb motor control,
range of movement, strength and proprioception to
allow full recovery. Labral repairs can now begin flex-
ing exercises. Phase four (>12 weeks) allows return to
sport. Running typically commences around eight
weeks and non-contact and contact sports at 3-4
months depending on the surgery type.
Outcome Measures
Twelve questions make up the FJS-12, shown in
Table 1. Each is scored on a Likert scale ranging from
0 to 4. The total sum of the scores is converted into a
scale ranging from 0 to 100, where higher scores reflect
less joint awareness during activities of daily living. The
iHOT-12 assesses the functional outcomes of hip
arthroscopy. A visual analog scale (VAS) is used to score
12 questions with the mean value of all questions
equating to the total iHOT-12 score. The score ranges
from 0 to 100 with a higher score reflecting less
symptoms and better function. The EuroQol-5 Dimen-
sion-5L (EQ-5D-5L) consists of an index score and a
visual analog scale. The index score contains five do-
mains which include mobility, self-care, usual activities,
pain/discomfort, and anxiety/depression. Scores range
from -0.594 to þ1 for the United Kingdom EQ-5D-5L
value set. The VAS is a self-assessment of a patient’s
health state and is scored from 0 to 100 on a 100mmscale. Patient satisfaction was assessed using a five-point
Likert scale.
An anchor-based approach was used to establish the
PASS. The anchor question used was modified from
that designed by Tubach et al. 33 Patients were asked
“How satisfied are you following your surgery?” The
response to the question was graded using a 5-point
Likert scale: very satisfied, satisfied, neither satisfied
or dissatisfied, dissatisfied or very dissatisfied. We
dichotomized responses for analysis, accepting ‘satis-
fied’ and ‘very satisfied’ responses as positive. Distri-
butional statistical methodology was used to calculate
the MCID.
Statistical Analysis
Statistical analysis was undertaken using Statistical
Package for Social Sciences (SPSS) software (IBM, Inc.,
Armonk, New York, United States) v24. Normality was
assessed using Shapiro-Wilk testing. Continuous, nor-
mally distributed data was reported as mean with
standard deviation and was compared using 2-tailed
student t-tests. Non-parametric data was reported as
median with interquartile range and compared using
Mann Whitney U-tests. Cross-tabulated data for
dichotomous variables were analyzed using chi squared
tests. A p-value of <0.05 was considered statistically
significant.
Receiver operator curve (ROC) analysis was used to
identify thresholds for the FJS-12 score that predicted a
satisfactory outcome. The area under a ROC curve
ranges from 0.5, indicating a test with no accuracy in
distinguishing the outcome variable (e.g. satisfaction),
to 1.0 where the test would be absolutely accurate at
identifying the outcome variable in all patients. The
threshold is equivalent to the point (FJS-12 score) at
which combined sensitivity and specificity are maximal
in predicting the outcome variable. A ROC curve with
an area under the curve of >0.7 is considered to
demonstrate a test with acceptable discriminatory po-
wer and >0.8 is considered excellent.34 For the pur-
poses of dichotomous statistical analysis pertaining to
satisfaction, patients stating they were ‘very satisfied’ or
‘satisfied’ were considered satisfied while all other re-
sponses were considered unsatisfied. Pearson correla-
tion analysis was used to correlate postoperative FJS-12
score with preoperative patient variables and other
PROMs. A correlation co-efficient for each test <0.2
was considered ‘very weak’, 0.2 to 0.39 was considered
‘weak’, 0.4 to 0.59 was considered ‘moderate’, and
greater than 0.6 was considered strong.35
Ethics Approval and Consent to Participate
Institutional review board approval was granted in
keeping with advice from the local research ethics ser-
vice (NHS HRA, South East Scotland Research Ethics
Committee).
Table 3. Patient Demographic Characteristics
n ¼ 77
Age 30.3 years (SD 8.2)
Gender 54 female/23 male
BMI 25.4 kg/m2 (SD 4.2)
Tönnis grade 57.1% 0, 42.9% 1
Preoperative Tegner score 4 (IQR 3 e 5)
Lateral center edge angle 37.50o (SD 8.86)
BMI, body mass index; SD, standard deviation; IQR, interquartile
range.
Table 1. Questions comprising The Forgotten Joint Score-12
1. Awareness in bed at night?
2. Awareness sitting on a chair for more than 1 hour?
3. Awareness when walking for more than 15 minutes?
4. Awareness when taking a bath or shower?
5. Awareness when traveling in a car?
6. Awareness when climbing stairs?
7. Awareness when walking on uneven ground?
8. Awareness when standing up from a low position?
9. Awareness when standing for long periods of time?
10. Awareness when doing housework or gardening?
11. Awareness when taking a walk or hiking?
12. Awareness when doing your favorite sport?
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Seventy-seven patients underwent hip arthroscopy at
our institution in the period under review, and 65 pa-
tients (84%) completed postoperative PROMs scores at
a mean follow up of 23.8 months (SD 6.4). No patients
were excluded. The specific surgical procedures per-
formed are detailed in Table 2. Demographic informa-
tion for the patient group is presented in Table 3.
Preoperative FJS-12 score range was 0 e 69. Pre- and
postoperative scores for the FJS-12, iHOT-12, EQ-5D
index, and VAS scores are shown in Table 4. Six pa-
tients progressed to require reoperation (two requiring
further arthroscopy, four requiring total hip
arthroplasty).
Change Between Preoperative and Postoperative
Scores
There was a mean change of 27.2 (SD 30.6) points
in FJS-12 score between pre- and postoperative re-
view (p < 0.001)(Table 4). Using the method of one
half of the standard deviation of the difference in
preoperative and postoperative outcome score to
quantify the MCID, we found this to be 15.3 points.
Thirty-seven patients (56.9%) met or surpassed the
MCID, 33 (89.2%) of which also achieved the PASS




With or without rim recession 49
With microfracture with or without rim recession 6
Labral resection
With or without rim recession 15
With microfracture and rim recession 6
With removal of loose body 1
Femoral procedure
Cam removal
Isolated cam removal 64
With osteophyte removal 9
With microfracture 3
Femoral procedure not recorded 1Satisfaction and FJS-12
Seventy-three patients answered the satisfaction
question. Of these, 25 stated they were very satisfied,
20 satisfied, 13 neither satisfied nor dissatisfied, 10
dissatisfied, and 5 very dissatisfied. As such 45 (61.6%)
respondents were coded as satisfied for analysis. Satis-
fied patients had greater mean improvement in the
FJS-12 compared to unsatisfied patients (P < .001;
Table 5). There was no significant difference in age,
gender distribution, or preoperative FJS-12 score be-
tween those who were satisfied and those who were
not satisfied (Table 6).
PASS for the FJS-12
The calculated PASS threshold for the absolute FJS-12
score at a mean follow-up of 23.8 months (SD 6.4) after
surgery was 38.5 points (sensitivity 80%, specificity
88%), and the area under the curve was 0.85 (95%
confidence interval 0.75-0.95) (Fig 1). There was a total
of 35 (53.8%) patients who achieved the PASS score.
Eleven patients had a preoperative FJS-12 score
exceeding the PASS threshold. Three of these failed to
achieve the PASS score after surgery because of
increased postoperative joint awareness, and 1 was lost
to follow-up.
Correlating FJS-12 Score With Postoperative Proms
and Preoperative Patient Factors
Univariate correlation analyses of postoperative FJS-
12 with preoperative patient characteristics are illus-
trated in Table 7. The strongest association with post-
operative FJS-12 score was seen with preoperative EQ-
5D-5L Index (r ¼ 0.557, P < .001) and preoperativeTable 4. Preoperative and Postoperative Patient-Reported
Outcome Measures
Preoperative Postoperative P Value
FJS-12 19.29 (SD 17.5) 46.5 (SD 33.1) <.001
iHOT-12 31.56 (SD 16.6) 59 (SD 28.1) <.001
EQ-5D-5L 0.493 (SD 0.250) 0.624 (SD 0.284) <.001
VAS 64.4 (SD 19.7) 71.2 (SD 21.1) .034
SD, standard deviation; FJS-12, Forgotten Joint Score-12; iHOT-12,
International Hip Outcome Tool 12; EQ-5D-5L, EuroQol-5
Dimension-5L; VAS, visual analog scale.
Table 5. Change in Preoperative and Postoperative FJS-12
Scores for Those Who Were Satisfied or Unsatisfied
Satisfied Patients Unsatisfied Patients P Value
FJS-12 62.3 (SD 29.8) 21.3 (SD 20.0) <.001
Change
in FJS-12
41.4 (SD 26.1) 4.6 (SD 22.7) <.001
SD, standard deviation; FJS-12, Forgotten Joint Scoree12.
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12 score was not significantly different between gen-
ders (P ¼ .701), according to the presence of pincer or
cam morphology (P ¼ .713, and P ¼ .202, respectively),
for patients with previous contralateral hip arthroscopy
(P ¼ .713) or for those undergoing revision surgery
(P ¼ .111). Postoperative FJS-12 score showed strong
significant correlations with postoperative iHOT-12
score (r ¼ 0.801, P < .001), EQ-5D-5L index (r ¼
0.748, P < .001), and VAS (r ¼ 0.671, P < .001).Table 6. Demographics and Preoperative FJS-12 Scores for
Patients Who Were Satisfied or Unsatisfied
Satisfied Patients Unsatisfied Patients
P
Value
Age (years) 31.3 (SD 8.5) 29.0 (SD 7.8) .248
Gender
distribution




(IQR 8.3 e 28.1)
10.4
(IQR 2.6 e 32.3)
.189
SD, standard deviation; FJS-12, Forgotten Joint Scoree12; IQR,
interquartile range.Discussion
The primary finding from this study was the identi-
fication of the PASS threshold for the FJS-12 (38.5
points). This threshold has an associated sensitivity and
specificity of 80% and 88%, respectively, and an area
under the curve of 0.85 (95% confidence interval 0.75-
0.95). Postoperative FJS-12 score showed strong cor-
relations with postoperative iHOT-12, EQ-5D-5L index,
and VAS score and also moderate strength correlation
with preoperative EQ-5D-5L index, iHOT-12, and FJS-
12 scores. The study hypothesis is confirmed, because
this PASS threshold is both highly sensitive and specific
for establishing whether patients have achieved an
acceptable symptomatic state after surgery.
A number of PROMs related to hip arthroscopy have
had PASS scores calculated, including the HOS-ADL,36
HOS-SS,36 iHOT-12,23,36-38 mHHS,39 and Nonarthritic
Hip Score.40 The wording of our anchor question was
very similar to others used in the PASS literature, which
allows for comparisons at face value. The 38.5 points
reported here as a PASS for the FJS-12 is surprisingly
low on the 0-100 score scale to qualify as an acceptable
outcome; however, this should be interpreted in light of
normative data for young healthy people, which sug-
gests 65.9 as the mean FJS-12 score.41 As with all PASS
calculations, this threshold is devised from the overall
cohort’s responses, and there will be individual patient-
dependent variation within this, as reflected by the 11
patients here with a preoperative FJS-12 score greater
than the PASS threshold.
Just over half of our patient cohort (53.8%) achieved
the PASS threshold for the FJS-12. This number is
lower than the proportions of hip arthroscopy patients
documented achieving PASS using different metrics,
such as the iHOT-12,23,38 the Nonarthritic Hip Score,40and the mHHS39 in similar patient cohorts. This could
be explained by the joint awareness construct being
distinct from measuring joint function.42 It is thought
that joint awareness is a more sensitive measure of joint
pathology, and therefore it is more challenging to score
highly after surgery. This likely explains why patients in
our cohort achieved the PASS threshold less frequently
than previous studies. However, it is also for this reason
that this outcome tool is effective in distinguishing good
from excellent performers after hip arthroscopy and
why it has been recommended for young, active pa-
tients.8 Other outcome tools used to assess hip
arthroscopy have demonstrated significant ceiling ef-
fects with an inability to distinguish good from excellent
outcomes.33 Our results here present a PASS score in
the lower half of possible scores on the 0-100 scale of
the FJS-12, suggesting that while not a sports-specific
score, the FJS-12 may be useful in assessing high-
performing patients. We appreciate that the FJS-12
should be used with skepticism because it was primar-
ily validated for arthroplasty, and early validation
studies for arthroscopy have including modest
numbers8,10; however its patient-centered approach is
likely to appeal to researchers and clinicians in
arthroscopy as it has done in arthroplasty.
Patients with better baseline function are more likely
to achieve acceptable postoperative symptom states and
this has been previously reported in the evaluation of
the Harris Hip Score,22 Western Ontario and McMaster
Universities Osteoarthritis Index (WOMAC), EuroQol-
5D (EQ-5D), and Oxford scores.18,19 Similarly, whilst
not a predictive analysis, the correlations presented
here suggest that higher levels of preoperative function
and symptomatology (as assessed by FJS-12, iHOT-12,
EQ-5D-5L index, and VAS) are associated with
improved postoperative joint awareness following hip
arthroscopy. There was a strong satisfaction link with
the success of surgery as measured by the FJS-12. Those
who were satisfied following surgery had a mean FJS-
12 score 41 points higher than those who were dissat-
isfied and had a mean increase in their score of 36.8
points more than dissatisfied patients. That those
dissatisfied with surgery had minimal change in
symptoms postoperatively is likely lowering the
Fig 1. Receiver operator characteristic (ROC)
curve for the threshold score of the FJS-12 to
determine the patient acceptable symptomatic
state.
e6 P. G. ROBINSON ET AL.threshold for PASS. Although only 38.5 points are
required to achieve PASS, the satisfied patients in our
cohort reported a mean FJS-12 of 62.3 points (essen-
tially the same as age-matched healthy populations). In
addition, postoperative quality of life scores and func-
tional scores were strongly correlated with the FJS-12,
suggesting that this outcome metric has propertiesTable 7. Univariate Correlation Analysis Between




SIMD vigintile 0.202 .109
Symptom duration 0.205 .110
Pre-injury Tegner score 0.169 .190
Lateral center-edge angle 0.104 .411
Tönnis classification 0.128 .310
Preoperative Tegner score 0.347 .006*
Preoperative FJS-12 score 0.404 .001*
Preoperative iHOT-12 score 0.451 <.001*
Preoperative EQ-5D-5L index 0.557 <.001*
Preoperative VAS 0.278 .025*
r, Pearson correlation coefficient; BMI, Body mass index; SIMD,
Scottish Index of Multiple Deprivation; FJS-12, Forgotten joint score-
12; iHOT-12, International hip outcome tool 12; EQ-5D-5L, EuroQol-
5 Dimension-5L; VAS, visual analog scale.
*Significant correlation (P < .05).that capture a total holistic view of the patient’s
outcome.
Limitations
This study is not without its limitations. It carries the
limitations typical of a retrospective case series,
including possible inconsistent reporting of data, loss to
follow-up (although this was limited to 16%), and the
absence of a control group. This study featured a rela-
tively modest sample size and large spread of data and
would benefit from a significantly larger dataset. The
minimum of 1 year of follow-up is a further limitation.
The continuing lack of an agreed gold-standard format
for anchor questions in the literature to determine pa-
tient satisfaction to allow PASS threshold calculation is
a limitation of all studies reporting this psychometric
statistic.33 Additionally, this study’s generalizability may
be limited by this being a single-surgeon series, as well
as by the mix of labral procedures (both debridement
and repair) and a United Kingdomebased population.
Conclusions
We report a postoperative PASS threshold of 38.5
points for the FJS-12 after hip arthroscopy for FAI in a
United Kingdom population. This value can act as a
quantifiable target for clinicians using the FJS-12 to
PASS OF THE FJS-12 AFTER HIP ARTHROSCOPY e7monitor patient outcomes in practice. FJS-12 has strong
correlations with EQ-5D-5L, iHOT-12 and VAS at
minimum 12 months postoperatively.References
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